by The global softgel capsules market size was valued at USD 8.71 billion in 2023 and is projected to grow around USD 17.19 billion by 2033 with a CAGR of 7.03% from 2024 to 2033.
Key Points
- North America led the market with the largest market share of 43% in 2023.
- By type, the gelatin-based/animal-based segment has accounted biggest market share in 2023.
- By application, the vitamins and dietary supplements segment held the largest share of the market in 2023.
- By end-use, the nutraceutical companies segment has contributed more than 38% of market share in 2023.
Softgel capsules have emerged as a popular and versatile pharmaceutical and nutraceutical dosage form, experiencing significant growth in the global market. These capsules are composed of a gelatin-based shell, which encases a liquid or semi-solid core containing the active ingredient. The softgel encapsulation technology has gained widespread acceptance due to its ease of swallowing, enhanced bioavailability, and suitability for a wide range of formulations.
The global softgel capsules market has witnessed substantial expansion, driven by factors such as the growing pharmaceutical and dietary supplements industries. The rise in consumer demand for easily consumable and convenient dosage forms has propelled the adoption of softgel capsules by pharmaceutical companies and nutraceutical manufacturers alike. Additionally, advancements in formulation technologies and the development of innovative shell materials have further contributed to the market’s evolution.
Get a Sample: https://www.precedenceresearch.com/sample/3929
Growth Factors
Several key factors contribute to the sustained growth of the softgel capsules market. One major driver is the increasing prevalence of chronic diseases, prompting a higher demand for pharmaceuticals. Softgel capsules offer advantages in drug delivery, facilitating the administration of potent and complex drug formulations. Furthermore, the expanding aging population worldwide has led to a surge in health-conscious consumers seeking dietary supplements, boosting the nutraceutical segment of the softgel capsules market.
Moreover, advancements in manufacturing processes, such as improved encapsulation techniques and automation, have streamlined production, resulting in cost efficiencies. The pharmaceutical industry’s continuous research and development efforts to enhance drug delivery systems and formulation technologies also contribute to the market’s positive trajectory.
Regions Insights
The softgel capsules market exhibits a dynamic geographical distribution, with various regions playing significant roles in its growth. North America and Europe, characterized by well-established pharmaceutical and nutraceutical industries, stand as major contributors to market revenue. These regions benefit from a high level of consumer awareness regarding the advantages of softgel capsules, coupled with robust healthcare infrastructure.
In the Asia-Pacific region, particularly in countries like China and India, the market experiences substantial growth due to the expanding pharmaceutical and dietary supplement sectors. The increasing disposable income, changing lifestyles, and a growing focus on preventive healthcare contribute to the rising demand for softgel capsules in the Asia-Pacific market.
Softgel Capsules Market Scope
| Report Coverage | Details |
| Growth Rate from 2024 to 2033 | CAGR of 7.03% |
| Global Market Size in 2023 | USD 8.71 Billion |
| Global Market Size by 2033 | USD 17.19 Billion |
| U.S. Market Size in 2023 | USD 2.81 Billion |
| U.S. Market Size by 2033 | USD 5.54 Billion |
| Base Year | 2023 |
| Forecast Period | 2024 to 2033 |
| Segments Covered | By Type, By Application, and By End-use |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Softgel Capsules Market Dynamics
Drivers:
Several drivers propel the softgel capsules market forward. Firstly, the pharmaceutical industry’s inclination towards patient-centric drug delivery systems fuels the adoption of softgel capsules. These capsules allow for precise dosage control and offer an effective means of delivering both hydrophilic and lipophilic drugs.
Secondly, the nutraceutical sector benefits from the inherent advantages of softgel capsules, such as improved stability and bioavailability of nutrients. The ease of incorporating various ingredients, including vitamins, minerals, and botanical extracts, into softgel formulations further drives their popularity in the nutraceutical market.
Additionally, the cosmetic and personal care industry has recognized the potential of softgel capsules for delivering skincare and beauty formulations. This diversification of applications contributes to the market’s growth as manufacturers explore new opportunities beyond traditional pharmaceutical and nutraceutical uses.
Restraints:
Despite the positive growth trajectory, the softgel capsules market faces certain challenges. One notable restraint is the preference for alternative dosage forms, such as tablets and hard capsules, driven by cost considerations and specific formulation requirements. The gelatin-based composition of softgel capsules also poses limitations for certain consumer segments, particularly vegetarians and those with religious or cultural restrictions on animal-derived products.
Furthermore, regulatory challenges associated with the approval and standardization of softgel capsule formulations can pose barriers to market entry. Compliance with diverse regional regulations and variations in quality standards may impact the expansion of manufacturers into new markets.
Opportunities:
The softgel capsules market is rife with opportunities for innovation and expansion. Manufacturers can explore novel materials for capsule shells, such as plant-based alternatives, addressing the concerns of vegetarian and vegan consumers. Additionally, the integration of advanced technologies, such as 3D printing for personalized capsules or the use of nanotechnology for targeted drug delivery, opens avenues for future growth.
Collaborations between pharmaceutical companies and contract manufacturing organizations (CMOs) can enhance production capabilities and provide a competitive edge. The exploration of untapped markets, especially in emerging economies with evolving healthcare landscapes, presents lucrative opportunities for market players willing to invest in expansion strategies
Read Also: Smart Home Healthcare Market Size to Rake USD 212.55 Bn by 2033
Recent Developments
- In May 2022, the launch of SOLFEROL Softgel Capsules, a line of reimbursed vitamin D3 medications, for the treatment of vitamin D insufficiency was announced by Windzor Pharma Ireland Ltd. This product has the broadest array of presentations available on the market, with two distinct strengths: 400 IU for treating expectant and nursing mothers and 20,000 IU for those with severe vitamin D3 deficiency.
- In December 2023, Amneal Pharmaceuticals and Strides Pharma Science Limited announced the launch of Icosapent ethyl acid soft gel capsules, a product that refers VASCEPA. Strides, a multinational pharmaceutical producer, has granted an in-license for the medicine, which Amneal will begin marketing in the fourth quarter of 2023. An ethyl ester of eicosapentaenoic acid (EPA), isicosapent ethyl acid soft gel capsules, 0.5g and 1g, are recommended as a dietary supplement to lower triglyceride levels in adult patients with severe (≥ 500 mg/dL) hypertriglyceridemia.
Softgel Capsules Market Players
- CAPTEK Softgel International Inc.
- Sirio Pharma Co., Ltd.
- Fuji Capsule
- Thermo Fisher Scientific Inc.
- EyePoint Pharmaceuticals, Inc.
- EuroCaps
- Catalent, Inc.
- Aenova Group
- ProCaps Laboratories, LLC
- Lonza Capsules & Health Ingredientss
- Soft Gel Technologies, Inc.
Segments Covered in the Report
By Type
- Non-Animal-Based
- Gelatin-Based/Animal-Based
By Application
- Anti-Inflammatory Drugs
- Antacid and Anti-Flatulent Preparation
- Antibiotic and Antibacterial Drugs
- Cough and Cold Preparations
- Anti-Anemic Preparations
- Vitamin and Dietary Supplement
- Health Supplement
- Pregnancy
By End-use
- Cosmeceutical Companies
- Nutraceutical Companies
- Pharmaceutical Companies
- Contract Manufacturing Organizations
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Web: https://www.precedenceresearch.com
Blog: https://www.expresswebwire.com/
Blog: https://www.uswebwire.com/
Blog: https://www.dailytechbulletin.com/
Blog: https://www.autoindustrybulletin.com/
